Reckitt Benkiser (Bangladesh) Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reckitt Benkiser (Bangladesh) Ltd with three other
pharmaceutical manufacturers in Asia:
Tus Pharmaceutical Group Co Ltd
of CHINA
(2019
sales of 315.03 million Chinese Renmimbi [US$48.95 million]
of which 91%
was Chinese medicine health care production ),
Korean Drug Co Ltd
of KOREA (SOUTH)
(55.53 billion Korean Won [US$49.81 million]
of which 40%
was Neuromed,CNS), and
Lincoln Pharmaceuticals Limited
which is
based in INDIA
(3.66 billion Indian Rupees [US$49.91 million]
).
Sales Analysis.
Reckitt Benkiser (Bangladesh) Ltd reported sales of 4.13 billion Bangladeshi Taka (US$49.56 million)
for the
year ending
December of 2019.
This
represents
an
increase of 6.0%
versus 2018, when the company's sales were 3.89 billion Bangladeshi Taka.
Sales at Reckitt Benkiser (Bangladesh) Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 55%).